Current Drug Safety
Title:Editorial (Thematic Issue: The Biologics in Clinical Practice: A Modern Approach for Inflammatory and Immune-Mediated Diseases)
Volume: 11 Issue: 1
Author(s): A. Offidani and A. Campanati
Affiliation:
Export Options
About this article
Cite this article as:
Offidani A. and Campanati A., Editorial (Thematic Issue: The Biologics in Clinical Practice: A Modern Approach for Inflammatory and Immune-Mediated Diseases), Current Drug Safety 2016; 11 (1) . https://dx.doi.org/10.2174/157488631101160212164644
DOI https://dx.doi.org/10.2174/157488631101160212164644 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Debates on Etiopathogenesis and Treatment Strategies for Vitiligo
Current Drug Targets Biological Treatments for SAPHO Syndrome: An Update
Inflammation & Allergy - Drug Targets (Discontinued) Preface [Hot Topic: Transcription Factors as Targets of Novel Therapeutic Approaches of Autoimmune Diseases (Executive Editor: Gunther Ne)]
Current Pharmaceutical Design Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews Editorial: [Hot Topic: Drug Development in Dermatology: New Targets for Old Diseases?]
Current Pharmaceutical Biotechnology HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Patent Selections
Recent Patents on Regenerative Medicine Vitamin D Analogs: Mechanism of Action and Therapeutic Applications
Current Medicinal Chemistry The Shape of the Messenger: Using Protein Structure Information to Design Novel Cytokine-based Therapeutics
Current Pharmaceutical Design Th1/Th17 Cytokine Profile is Induced by Macrophage Migration Inhibitory Factor in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients
Current Molecular Medicine Inhibitors of TACE and Caspase-1 As Anti-inflammatory Drugs
Current Medicinal Chemistry Cardiovascular Disease in Juvenile Idiopathic Arthritis
Current Vascular Pharmacology Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors
Current Topics in Medicinal Chemistry Inhibitors of the Enzyme Purine Nucleoside Phosphorylase as Potential Therapy for Psoriasis
Current Pharmaceutical Design Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry New Drugs for Immune Targeting
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis?
Current Pharmaceutical Design Pinpoint and Stewardship of Psoriasis by Using Phytoconstituent-based Novel Formulation
Current Bioactive Compounds IL-24: Physiological and Supraphysiological Effects on Normal and Malignant Cells
Current Medicinal Chemistry Molecular Pathways of Endothelial Cell Activation for (Targeted) Pharmacological Intervention of Chronic Inflammatory Diseases
Current Vascular Pharmacology